vimarsana.com
Home
Live Updates
Grey Wolf Therapeutics Closes Oversubscribed $49 Million Ser
Grey Wolf Therapeutics Closes Oversubscribed $49 Million Ser
Grey Wolf Therapeutics Closes Oversubscribed $49 Million Series B Financing to Advance First-of-its-Kind Neoantigen Creation Approaches
/PRNewswire/ -- Grey Wolf Therapeutics, a biotechnology company focused on generating entirely novel anti-tumour immune responses through targeted cancer...
Related Keywords
Australia ,
United Kingdom ,
British ,
Sally Dewhurst ,
Rabab Nasrallah ,
Peter Joyce ,
Emma Johnson ,
Marie Claire Peakman ,
Syndicate Of Life Science Industry Investors ,
Oxford Science Enterprises ,
Premier Syndicate ,
Life Science Industry Investors ,
Pfizer Ventures ,
Earlybird Venture Capital ,
Andera Partners ,
British Patient ,
Support Advancement ,
Lead Candidate ,
Wolf Therapeutics ,
British Patient Capital ,
Wolf Therapeutic ,
Grey Wolf ,
Earlybird Venture ,
Grey Wolf Therapeutics ,
Oxford Science ,
Claire Peakman ,
Strategic Partners ,